Bpifrance SA Long-Term Concentrated

CIK: 0001731118 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value ($000): $879,282 (100.0% shares, 0.0% debt)

Holdings (8)

FTI TECHNIPFMC PLC 65.7%

Value ($000) $578,055 Shares 24,688,691 Est. Cost $17.41 Unrealized -8.7%

— CONSTELLIUM NV 14.9%

Value ($000) $130,823 Shares 16,393,903 Est. Cost $6.99 Unrealized —

— TALEND S A 9.3%

Value ($000) $81,564 Shares 1,612,895 Est. Cost $37.08 Unrealized —

CRTO CRITEO S A 6.2%

Value ($000) $54,457 Shares 2,718,752 Est. Cost $22.72 Unrealized —

— MILLENDO THERAPEUTICS INC 1.8%

Value ($000) $16,180 Shares 1,078,670 Est. Cost $7.95 Unrealized —

— SEQUANS COMMUNICATIONS S A 1.5%

Value ($000) $13,315 Shares 12,085,561 Est. Cost $0.78 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 0.5%

Value ($000) $4,340 Shares 828,262 Est. Cost $3.15 Unrealized —

MITK MITEK SKS INC 0.1%

Value ($000) $548 Shares 44,754 Est. Cost $9.04 Unrealized +24.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
FTI	TECHNIPFMC PLC	24,688,691	$578,055	65.7%	$17.41	-8.7%	COM	G87110105
—	CONSTELLIUM NV	16,393,903	$130,823	14.9%	$6.99	—	CL A	N22035104
—	TALEND S A	1,612,895	$81,564	9.3%	$37.08	—	ADS	874224207
CRTO	CRITEO S A	2,718,752	$54,457	6.2%	$22.72	—	SPONS ADS	226718104
—	MILLENDO THERAPEUTICS INC	1,078,670	$16,180	1.8%	$7.95	—	COM	60040X103
—	SEQUANS COMMUNICATIONS S A	12,085,561	$13,315	1.5%	$0.78	—	SPONS ADS	817323108
—	ADVERUM BIOTECHNOLOGIES INC	828,262	$4,340	0.5%	$3.15	—	COM	00773U108
MITK	MITEK SKS INC	44,754	$548	0.1%	$9.04	+24.1%	COM NEW	606710200